A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies

<div>(a) Bone marrow biopsy with 400x H&amp;E stain showed diffuse infiltrate and characterized by medium-to-large cells with irregular nuclear contour, prominent nucleoli, and cytoplasmic vacuoles. Brisk mitosis identified. (b) Colon biopsy with 400x H&amp;E stain showed intermediate-sized lymphoid cells with scattered histiocytes imparting a “starry sky” pattern.</div>

Case Reports in Oncological Medicine

fig2

Figure 2

Figure 2: A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies 

Figure 2 | A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies 